KRT31

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, KRT31 mutation is significantly associated with the drug of many other genes, with 52 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible KRT31-associated genes across cancer lineages are Axitinib, LMP744, and Bosutinib. Each is linked with KRT31 in more than 1 cancer types. Because this analysis shows association rather than direction, both KRT31-to-partner and partner-to-KRT31 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Axitinib grouped by KRT31-low versus KRT31-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (KRT31→partner) and Y-score (partner→KRT31) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEAxitinib →+0.574+2.807.035.04632
LARGE_INTESTINELMP744 →+0.786+2.710.019.02732
LARGE_INTESTINEBosutinib →+0.525+2.700.002.03031
LARGE_INTESTINETanespimycin →+0.496+2.807.045.04631
LARGE_INTESTINEAZD8055 →+0.516+2.807.032.04631
LARGE_INTESTINEI-BET-762 →+0.577+2.868.011.02231
Each partner links to its Q-omics profile. Showing the 6 strongest of 52 associations by consensus.

Axitinib by KRT31 expression — LARGE_INTESTINE

Box plot of Axitinib in KRT31-low vs KRT31-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration